By Professor Steven Krilis

Journal articles

Sheng YH; Sali A; Herzog H; Lahnstein J; Krilis S, 1996, 'Site directed mutagenesis of recombinant human b2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anticardiolipin antibody cofactor activity', Journal of Immunology, 157, pp. 3744 - 3751

Krilis S; Sheng YH; Kandiah DA, 1996, 'The role of b2-glycoprotein I in the Antiphospholipid Syndrome', Lupus, pp. 150 - 152

Kandiah DA; Hunt JE; Krilis SA, 1995, 'Epitope mapping studies of antiphospholipid antibodies and β 2 -GPI using synthetic peptides', Lupus, 4, http://dx.doi.org/10.1177/096120339400400103

Kandiah DA; Hunt JE; Krilis SA, 1995, 'Epitope mapping studies of antiphospholipid antibodies and β2-GPI using synthetic peptides', Lupus, 4, http://dx.doi.org/10.1177/096120339400400103

Krilis SA, 1995, 'Interview with Steven A. Krilis. What is going to happen tomorrow for beta 2-glycoprotein I?', Annales de Medecine Interne, 146, pp. 212 - 214

Li L; Macpherson J; Adelstein S; Bunn CL; Atkinson K; Phadke K; Krilis S, 1995, 'Conditioned media from a cell strain derived from a patient with mastocytosis induces preferential development of cells that posses high affinity IgE receptors and the granule protease phenotype of mature cutaneous mast cells', The Journal of Biological Chemistry, pp. 2258 - 2263

Li L; Macpherson J; Adelstein S; Bunn CL; Atkinson K; Phadke K; Krilis S, 1995, 'Conditioned media from a cell strain derived from a patient with mastocytosis induces preferential development of cells that possess high affinity IgE receptors and the granule protease phenotype of mature cutaneous mast cells', The Journal of Biological Chemistry, pp. 2258 - 2263

Li L; Macpherson J; Adelstein S; Bunn CL; Atkinson K; Phadke K; Krilis S, 1995, 'Conditioned medium from a cell strain derived from a patient with mastocytosis induces the development of mature human mastocytosis cells in vitro from normal human bone marrow', International Archives of Allergy and Applied Immunology, 107, pp. 142 - 144

Wang M; Kandiah DA; Ichikawa K; Khamashta M; Hughes GJ; Kioke T; Roubey R; Krilis S, 1995, 'Epitope specificity of monoclonal anti-B2-glycoprotein 1 antibodies derived from patients with the antipholipid syndrome', Journal of Immunology, 155, pp. 1629 - 1636

Kouts S; Wang M; Adelstein S; Krilis S, 1995, 'Immunization of a rabbit with B2-glycoprotein 1 induces charge-dependent crossreactive antibodies that bind anionic phospholipids and similar reactivity as autoimmune antibodies', Journal of Immunology, 155, pp. 958 - 966

Kouts S; Wang M; Adelstein S; Krilis S, 1995, 'Immunization of a rabbit with beta-2-glycoprotein I induces charge dependent cross-reactive antibodies that bind anionic phospholipids and have similar reactivity to autoimmune phosphoilpid antibodies', Journal of Immunology, 155, pp. 958 - 966

Hunt JE; Adelstein S; Krilis SA, 1994, 'New basic aspects of the antiphospholipid syndrome', Clinical and Experimental Rheumatology, 12, pp. 661 - 668

Hunt J; Krilis S, 1994, 'The fifth domain of β2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies', Journal of Immunology, 152, pp. 653 - 659

Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ, 1994, 'Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis', Clinical Nephrology, 41, pp. 18 - 22

Hunt JE; Simpson RJ; Krilis SA, 1993, 'Identification of a region of β2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity', Proceedings of the National Academy of Sciences of the United States of America, 90, pp. 2141 - 2145

Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM, 1993, 'Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: Their correlation with anticardiolipin antibodies and p2 glycoprotein-i plasma levels', Autoimmunity, 16, pp. 245 - 249, http://dx.doi.org/10.3109/08916939309014642

Hunt JE; Krilis SA, 1993, 'Antiphosphotipid Antibodies, β2-Glycoprotein I and Thrombosis', Lupus, 2, pp. 285 - 287, http://dx.doi.org/10.1177/096120339300200501

Kouts S; Bunn CL; Steinkasserer A; Krilis S, 1993, 'Expression of human recombinant β2-glycoprotein I with anticardiolipin antibody cofactor activity', FEBS Letters, 326, pp. 105 - 108, http://dx.doi.org/10.1016/0014-5793(93)81771-Q

Townsend M; Macpherson J; Krilis S; Reddell R; Symonds1 G, 1993, 'Immortalization and characterization of human cell lines with mast cell and monocytic properties', British Journal of Haematology, 85, pp. 452 - 461, http://dx.doi.org/10.1111/j.1365-2141.1993.tb03332.x

Hunt JE; McNeil HP; Morgan GJ; Crameri RM; Krilis SA, 1992, 'A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection.', Lupus, 1, pp. 75 - 81, http://dx.doi.org/10.1177/096120339200100204

McNeil HP; Hunt JE; KRILIST SA, 1992, 'Antiphospholipid Antibodies–New Insights into their Specificity and Clinical Importance', Scandinavian Journal of Immunology, 36, pp. 647 - 650, http://dx.doi.org/10.1111/j.1365-3083.1992.tb03124.x

Macpherson JL; Lopez A; Krilis SA, 1992, 'Co-culture of human bone marrow cells with a mastocytosis cell strain induces mast cell/basophil differentiation', International Archives of Allergy and Immunology, 99, pp. 346 - 349, http://dx.doi.org/10.1159/000236281

Krilis SA; Austen KF; Macpherson JL; Nicodemus CF; Gurish MF; Stevens RL, 1992, 'Continuous release of secretory granule proteoglycans from a cell strain derived from the bone marrow of a patient with diffuse cutaneous mastocytosis', Blood, 79, pp. 144 - 151

VLACHOYIANNOPOULOS PG; KRILIS SA; HUNT JE; MANOUSSAKIS MN; MOUTSOPOULOS HM, 1992, 'Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and β2‐glycoprotein‐l plasma levels', European Journal of Clinical Investigation, 22, pp. 482 - 487, http://dx.doi.org/10.1111/j.1365-2362.1992.tb01494.x

Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA, 1992, 'Production and characterization of antibodies to platelet-activating factor', Journal of Lipid Mediators, 5, pp. 49 - 59

Krilis SA; Warneford SG; Macpherson J; Kyradji S; Dalla-Pozza L; Kemp A; Mitchell R; Chesterman CN; Rowe PB; Symonds G, 1991, 'Establishment in culture and characterization of a strain with mast cell and monocytic properties from the bone marrow of a child with diffuse cutaneous mastocytosis', Blood, 78, pp. 290 - 303

Krilis SA; Warneford SG; Macpherson J; Kyradji S; Dalla-Pozza L; Kemp A; Mitchell R; Chesterman CN; Rowe PB; Symonds G, 1991, 'Establishment in culture and characterization of a strain with mast cell and monocytic properties from the bone marrow of a child with diffuse cutaneous mastocytosis', Blood, 78, pp. 290 - 303, http://dx.doi.org/10.1182/blood.v78.2.290.290

KRILIS SA; MACPHERSON J; WARNEFORD SG; KYRADJI S; MITCHELL R; CHESTERMAN CN; KEMP AS; ROWE PB; SYMONDS G, 1991, 'A HUMAN BONE-MARROW DERIVED MASTOCYTOSIS CELL STRAIN', FASEB JOURNAL, 5, pp. A1274 - A1274, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991FC55002073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

HUNT JE; MCNEIL HP; KRILIS SA, 1991, 'ANTICARDIOLIPIN ANTIBODIES FROM AUTOIMMUNE-DISEASE AND INFECTION HAVE DIFFERENT BINDING SPECIFICITIES', FASEB JOURNAL, 5, pp. A1088 - A1088, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991FC55000993&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McNeil HP; Krilis SA, 1991, 'Antiphospholipid antibodies.', Australian and New Zealand journal of medicine, 21, pp. 463 - 475, http://dx.doi.org/10.1111/j.1445-5994.1991.tb01356.x

Krilis SA, 1991, 'Immunochemistry of antiphospholipid antibodies', Clinical Immunology Newsletter, 11, pp. 37 - 41, http://dx.doi.org/10.1016/0197-1859(91)90027-P

McNeil HP, 1991, 'Immunology and clinical importance of antiphospholipid antibodies', Advances in Immunology, 49, pp. 193 - 280

McNeil HP; Krilis SA; Chesterman CN, 1991, 'New insights into the immunology of antiphospholipid antibodies', Hematology Reviews and Communications, 5, pp. 49 - 57

McNeil HP; Hunt JE; Krilis SA, 1990, 'New aspects of anticardiolipin antibodies', Clinical and Experimental Rheumatology, 8, pp. 525 - 527

Grandordy BM; Lacroix H; Mavoungou E; Krilis S; Crea AEG; Spur BW; Lee TH, 1990, 'Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils', Biochemical and Biophysical Research Communications, 167, pp. 1022 - 1029, http://dx.doi.org/10.1016/0006-291X(90)90625-W

Ang C; Clark E; Young. I; Owe-Young R; Eyland A; Hunt J; Chesterman. C; Krilis. S, 1990, '15-Hydroxyeicosatetraenoic acid synthesis from exogenous arachidonate by bronchial mucosa', Journal of Lipid Mediators, 2, pp. 263 - 269

McNeil HP; Simpson RJ; Chesterman CN; Krilis SA, 1990, 'Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-Glycoprotein I (apolipoprotein H)', Proceedings of the National Academy of Sciences of the United States of America, 87, pp. 4120 - 4124

McNeil HP; Gavaghan TP; Krilis SA; Geczy AF; Chesterm an CN, 1990, 'HLA-DR antigens and anticardiolipin antibodies', Clinical and Experimental Rheumatology, 8, pp. 425 - 426

Atkinson YH; Murray AW; Krilis S; Vadas MA; Lopez AF, 1990, 'Human tumour necrosis factor-alpha (TNF-α) directly stimulates arachidonic acid release in human neutrophils', Immunology, 70, pp. 82 - 87

Gavaghan TP; Hickie JB; Krilis SA; Baron DW; Gebski V; Low J; Chesterman CN, 1990, 'Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: Response to low dose aspirin', Journal of the American College of Cardiology, 15, pp. 1250 - 1258, http://dx.doi.org/10.1016/S0735-1097(10)80009-9

Shi W; Krilis SA; Chong BH; Gordon S; Chesterman CN, 1990, 'Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population', Australian and New Zealand Journal of Medicine, 20, pp. 231 - 236, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01025.x

McNeil HP; Chesterman CN; Krilis SA, 1989, 'Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics', British Journal of Haematology, 73, pp. 506 - 513, http://dx.doi.org/10.1111/j.1365-2141.1989.tb00289.x

Macpherson JL; Kemp A; Rogers M; Mallet AI; Toia RF; Spur B; Earl JW; Chesterman CN; Krilis SA, 1989, 'Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis', Clinical and Experimental Immunology, 77, pp. 391 - 396

McNeil HP; Chesterman CN; Krilis SA, 1988, 'Binding specificity of lupus anticoagulants and anticardiolipin antibodies', Thrombosis Research, 52, pp. 609 - 619, http://dx.doi.org/10.1016/0049-3848(88)90133-8

McNeil HP; Krilis SA; Chesterman CN, 1988, 'Purification of antiphospholipid antibodies using a new affinity method', Thrombosis Research, 52, pp. 641 - 648, http://dx.doi.org/10.1016/0049-3848(88)90136-3

GAVAGHAN TP; BARON DW; KRILIS SA; HICKIE JB; KEOGH AM; CHESTERMAN CN, 1988, 'ASPIRIN PROTECTS AGAINST CORONARY-ARTERY BYPASS GRAFT OCCLUSION IN PATIENTS WITH ANTIBODIES TO CARDIOLIPIN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 387 - 387, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

MCNEIL HP; KRILIS SA; CHESTERMAN CN, 1988, 'IMMUNO-AFFINITY PURIFICATION AND CHARACTERIZATION OF ANTIPHOSPHOLIPID ANTIBODIES', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 520 - 520, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000671&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

MACPHERSON J; KEMP AS; ROGERS M; TOIA RF; SPUR B; EARL JW; CHESTERMAN CN; KRILIS SA, 1988, 'THE OCCURRENCE OF PLATELET ACTIVATING FACTOR (PAF) AND AN ENDOGENOUS INHIBITOR OF PAF IN CONGENITAL DIFFUSE CUTANEOUS MACROCYTOSIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 453 - 453, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000419&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gavaghan TP; Krilis SA; Daggard GE; Baron DE; Hickie JB; Chesterman CN, 1987, 'ANTICARDIOLIPIN ANTIBODIES AND OCCLUSION OF CORONARY ARTERY BYPASS GRAFTS', The Lancet, 330, pp. 977 - 978, http://dx.doi.org/10.1016/S0140-6736(87)91470-X

MORTON KE; GAVAGHAN TP; KRILIS SA; DAGGARD GE; BARON DW; HICKIE JB; CHESTERMAN CN, 1987, 'CORONARY-ARTERY BYPASS GRAFT OCCLUSION - A ROLE FOR ANTIPHOSPHOLIPID ANTIBODIES', FEDERATION PROCEEDINGS, 46, pp. 978 - 978, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G323403860&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page